Literature DB >> 24627593

Spinal cord involvement in patients with cirrhosis.

Raffaele Nardone1, Yvonne Höller1, Monica Storti1, Piergiorgio Lochner1, Frediano Tezzon1, Stefan Golaszewski1, Francesco Brigo1, Eugen Trinka1.   

Abstract

A severe spinal cord involvement may rarely occur in patients with cirrhosis and other chronic liver diseases; this complication is usually associated with overt liver failure and surgical or spontaneous porto-systemic shunt. Hepatic myelopathy (HM) is characterized by progressive weakness and spasticity of the lower extremities, while sensory and sphincter disturbances have rarely been described and are usually less important. The diagnosis is assigned in the appropriate clinical setting on clinical grounds after the exclusion of other clinical entities leading to spastic paraparesis. Magnetic resonance imaging is often unremarkable; however, also intracerebral corticospinal tract abnormalities have been reported recently. The study of motor evoked potentials may disclose central conduction abnormalities even before HM is clinically manifest. HM responds poorly to blood ammonia-lowering and other conservative medical therapy. Liver transplantation represents a potentially definitive treatment for HM in patients with decompensated cirrhosis of Child-Pugh B and C grades. Other surgical treatment options in HM include surgical ligation, shunt reduction, or occlusion by interventional procedures.

Entities:  

Keywords:  Chronic liver disease; Cirrhosis; Endovascular procedures; Hepatic myelopathy; Liver transplantation; Porto-systemic shunt; Spastic paraparesis

Mesh:

Year:  2014        PMID: 24627593      PMCID: PMC3949266          DOI: 10.3748/wjg.v20.i10.2578

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  56 in total

1.  PERMANENT PARAPLEGIA WITH CIRRHOSIS.

Authors:  B A SCOBIE; W H SUMMERSKILL
Journal:  Arch Intern Med       Date:  1964-06

2.  Amplatzer Vascular Plug to occlude the internal iliac arteries in patients undergoing aortoiliac aneurysm repair.

Authors:  Chi D Ha; David Calcagno
Journal:  J Vasc Surg       Date:  2005-12       Impact factor: 4.268

3.  The Amplatzer vascular plug.

Authors:  H A White; S J Travis
Journal:  Cardiovasc Intervent Radiol       Date:  2008-01-08       Impact factor: 2.740

4.  Hepato-lenticular degeneration; a case associated with postero-lateral column degeneration.

Authors:  A D LEIGH; W I CARD
Journal:  J Neuropathol Exp Neurol       Date:  1949-07       Impact factor: 3.685

5.  Spastic paraparesis following portacaval shunts.

Authors:  S S Pant; J J Rebeiz; E P Richardson
Journal:  Neurology       Date:  1968-02       Impact factor: 9.910

6.  Hepatic cirrhosis with post-shunt myelopathy.

Authors:  M Bechar; M Freud; E Kott; I Kott; H Kravvic; J Stern; U Sandbank; B Bornstein
Journal:  J Neurol Sci       Date:  1970-08       Impact factor: 3.181

7.  Hepatic myelopathy. Case report with review of the literature.

Authors:  J V Campellone; D Lacomis; M J Giuliani; F J Kroboth
Journal:  Clin Neurol Neurosurg       Date:  1996-08       Impact factor: 1.876

8.  "Hepatic paraplegia": an uncommon complication of portosystemic shunt.

Authors:  G Budillon; D Mansi; G Scala; G Campanella
Journal:  Acta Neurol (Napoli)       Date:  1979-04

9.  Paraparesis, hypermanganesaemia, and polycythaemia: a novel presentation of cirrhosis.

Authors:  S M Gospe; R D Caruso; M S Clegg; C L Keen; N R Pimstone; J M Ducore; S S Gettner; R A Kreutzer
Journal:  Arch Dis Child       Date:  2000-11       Impact factor: 3.791

10.  Corticospinal involvement in patients with a portosystemic shunt due to liver cirrhosis: a MEP study.

Authors:  Raffaele Nardone; Thomas Buratti; Antonio Oliviero; Andreas Lochmann; Frediano Tezzon
Journal:  J Neurol       Date:  2005-08-04       Impact factor: 6.682

View more
  7 in total

1.  Liver transplantation in hepatic myelopathy.

Authors:  Sencan Acar; Ayhan Dinckan; Murat Akyildiz
Journal:  Hepatol Forum       Date:  2022-04-26

2.  Usefulness of Simplified Nutritional Appetite Questionnaire (SNAQ) in Appetite Assessment in Elder Patients with Liver Cirrhosis.

Authors:  T Wang; J Shen
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

Review 3.  Neurologic manifestations of gastrointestinal and liver diseases.

Authors:  José M Ferro; Sofia Oliveira
Journal:  Curr Neurol Neurosci Rep       Date:  2014-10       Impact factor: 5.081

4.  A(a)LS: Ammonia-induced amyotrophic lateral sclerosis.

Authors:  Bhavin Parekh
Journal:  F1000Res       Date:  2015-05-14

5.  Alcoholic Myelopathy and Nutritional Deficiency.

Authors:  Haruki Koike; Tomohiko Nakamura; Shohei Ikeda; Mie Takahashi; Yuichi Kawagashira; Masahiro Iijima; Masahisa Katsuno; Gen Sobue
Journal:  Intern Med       Date:  2017-01-01       Impact factor: 1.271

6.  Liver Transplantation Reverses Hepatic Myelopathy in 2 Children With Hepatitis A Infection.

Authors:  Roshan Koul; Bikrant Bihari Lal; Viniyendra Pamecha; Shiv Sarin; Seema Alam
Journal:  Child Neurol Open       Date:  2021-01-11

7.  Spinal Cord Injury Reduces Serum Levels of Fibroblast Growth Factor-21 and Impairs Its Signaling Pathways in Liver and Adipose Tissue in Mice.

Authors:  Xin-Hua Liu; Zachary A Graham; Lauren Harlow; Jiangping Pan; Daniella Azulai; William A Bauman; Joshua Yarrow; Christopher P Cardozo
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-11       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.